OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cholinesterase inhibitors for Alzheimer's disease
Jacqueline Birks
Cochrane library (2006) Vol. 2016, Iss. 3
Open Access | Times Cited: 1817
Jacqueline Birks
Cochrane library (2006) Vol. 2016, Iss. 3
Open Access | Times Cited: 1817
Showing 1-25 of 1817 citing articles:
Dementia prevention, intervention, and care
Gill Livingston, Andrew Sommerlad, Vasiliki Orgeta, et al.
The Lancet (2017) Vol. 390, Iss. 10113, pp. 2673-2734
Open Access | Times Cited: 5468
Gill Livingston, Andrew Sommerlad, Vasiliki Orgeta, et al.
The Lancet (2017) Vol. 390, Iss. 10113, pp. 2673-2734
Open Access | Times Cited: 5468
Alzheimer's disease
Kaj Blennow, Mony J. de Leon, Henrik Zetterberg
The Lancet (2006) Vol. 368, Iss. 9533, pp. 387-403
Closed Access | Times Cited: 2869
Kaj Blennow, Mony J. de Leon, Henrik Zetterberg
The Lancet (2006) Vol. 368, Iss. 9533, pp. 387-403
Closed Access | Times Cited: 2869
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
Justin M. Long, David M. Holtzman
Cell (2019) Vol. 179, Iss. 2, pp. 312-339
Open Access | Times Cited: 2339
Justin M. Long, David M. Holtzman
Cell (2019) Vol. 179, Iss. 2, pp. 312-339
Open Access | Times Cited: 2339
Acetylcholinesterase Inhibitors: Pharmacology and Toxicology
Mirjana B. Čolović, Danijela Krstić, Tamara Lazarević‐Pašti, et al.
Current Neuropharmacology (2013) Vol. 11, Iss. 3, pp. 315-335
Open Access | Times Cited: 2225
Mirjana B. Čolović, Danijela Krstić, Tamara Lazarević‐Pašti, et al.
Current Neuropharmacology (2013) Vol. 11, Iss. 3, pp. 315-335
Open Access | Times Cited: 2225
Alzheimer's disease
Chris Lane, John Hardy, Jonathan M. Schott
European Journal of Neurology (2017) Vol. 25, Iss. 1, pp. 59-70
Open Access | Times Cited: 2007
Chris Lane, John Hardy, Jonathan M. Schott
European Journal of Neurology (2017) Vol. 25, Iss. 1, pp. 59-70
Open Access | Times Cited: 2007
Bright Side of Lignin Depolymerization: Toward New Platform Chemicals
Zhuohua Sun, Bálint Fridrich, Alessandra De Santi, et al.
Chemical Reviews (2018) Vol. 118, Iss. 2, pp. 614-678
Open Access | Times Cited: 1779
Zhuohua Sun, Bálint Fridrich, Alessandra De Santi, et al.
Chemical Reviews (2018) Vol. 118, Iss. 2, pp. 614-678
Open Access | Times Cited: 1779
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
Kaj Blennow, Harald Hampel, Michael W. Weiner, et al.
Nature Reviews Neurology (2010) Vol. 6, Iss. 3, pp. 131-144
Closed Access | Times Cited: 1760
Kaj Blennow, Harald Hampel, Michael W. Weiner, et al.
Nature Reviews Neurology (2010) Vol. 6, Iss. 3, pp. 131-144
Closed Access | Times Cited: 1760
The Hawthorne Effect: a randomised, controlled trial
Rob McCarney, James Warner, Steve Iliffe, et al.
BMC Medical Research Methodology (2007) Vol. 7, Iss. 1
Open Access | Times Cited: 1563
Rob McCarney, James Warner, Steve Iliffe, et al.
BMC Medical Research Methodology (2007) Vol. 7, Iss. 1
Open Access | Times Cited: 1563
Effect of Physical Activity on Cognitive Function in Older Adults at Risk for Alzheimer Disease
Nicola T. Lautenschlager, Kay L. Cox, Leon Flicker, et al.
JAMA (2008) Vol. 300, Iss. 9, pp. 1027-1027
Closed Access | Times Cited: 1550
Nicola T. Lautenschlager, Kay L. Cox, Leon Flicker, et al.
JAMA (2008) Vol. 300, Iss. 9, pp. 1027-1027
Closed Access | Times Cited: 1550
Alzheimer's disease: clinical trials and drug development
Francesca Mangialasche, Alina Solomon, Bengt Winblad, et al.
The Lancet Neurology (2010) Vol. 9, Iss. 7, pp. 702-716
Closed Access | Times Cited: 1166
Francesca Mangialasche, Alina Solomon, Bengt Winblad, et al.
The Lancet Neurology (2010) Vol. 9, Iss. 7, pp. 702-716
Closed Access | Times Cited: 1166
Multi-target-Directed Ligands To Combat Neurodegenerative Diseases
Andrea Cavalli, María Laura Bolognesi, Anna Minarini, et al.
Journal of Medicinal Chemistry (2008) Vol. 51, Iss. 3, pp. 347-372
Closed Access | Times Cited: 1040
Andrea Cavalli, María Laura Bolognesi, Anna Minarini, et al.
Journal of Medicinal Chemistry (2008) Vol. 51, Iss. 3, pp. 347-372
Closed Access | Times Cited: 1040
Diagnosis and Management of Dementia: Review
Zoe Arvanitakis, Raj C. Shah, David A. Bennett
JAMA (2019) Vol. 322, Iss. 16, pp. 1589-1589
Open Access | Times Cited: 1006
Zoe Arvanitakis, Raj C. Shah, David A. Bennett
JAMA (2019) Vol. 322, Iss. 16, pp. 1589-1589
Open Access | Times Cited: 1006
Targeting Free Radicals in Oxidative Stress-Related Human Diseases
Patrik Poprac, Klaudia Jomová, Miriama Šimunková, et al.
Trends in Pharmacological Sciences (2017) Vol. 38, Iss. 7, pp. 592-607
Closed Access | Times Cited: 1000
Patrik Poprac, Klaudia Jomová, Miriama Šimunková, et al.
Trends in Pharmacological Sciences (2017) Vol. 38, Iss. 7, pp. 592-607
Closed Access | Times Cited: 1000
Dementia and Cognitive Impairment
Julie Hugo, Mary Ganguli
Clinics in Geriatric Medicine (2014) Vol. 30, Iss. 3, pp. 421-442
Open Access | Times Cited: 735
Julie Hugo, Mary Ganguli
Clinics in Geriatric Medicine (2014) Vol. 30, Iss. 3, pp. 421-442
Open Access | Times Cited: 735
Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care populations
Sam Creavin, Susanna Wisniewski, Anna H Noel-Storr, et al.
Cochrane library (2016) Vol. 2016, Iss. 4
Open Access | Times Cited: 723
Sam Creavin, Susanna Wisniewski, Anna H Noel-Storr, et al.
Cochrane library (2016) Vol. 2016, Iss. 4
Open Access | Times Cited: 723
Therapeutics of Alzheimer's disease: Past, present and future
R. Anand, Kiran Dip Gill, Abbas Ali Mahdi
Neuropharmacology (2013) Vol. 76, pp. 27-50
Closed Access | Times Cited: 711
R. Anand, Kiran Dip Gill, Abbas Ali Mahdi
Neuropharmacology (2013) Vol. 76, pp. 27-50
Closed Access | Times Cited: 711
Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system - too little activation is bad, too much is even worse
Chris G. Parsons, Albrecht Stöffler, Wojciech Danysz
Neuropharmacology (2007) Vol. 53, Iss. 6, pp. 699-723
Closed Access | Times Cited: 644
Chris G. Parsons, Albrecht Stöffler, Wojciech Danysz
Neuropharmacology (2007) Vol. 53, Iss. 6, pp. 699-723
Closed Access | Times Cited: 644
Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI)
Ingrid Arévalo-Rodríguez, Nadja Smailagic, Marta Roqué i Figuls, et al.
Cochrane library (2015)
Open Access | Times Cited: 625
Ingrid Arévalo-Rodríguez, Nadja Smailagic, Marta Roqué i Figuls, et al.
Cochrane library (2015)
Open Access | Times Cited: 625
Guiding Principles for the Care of Older Adults with Multimorbidity: An Approach for Clinicians
Journal of the American Geriatrics Society (2012) Vol. 60, Iss. 10
Open Access | Times Cited: 592
Journal of the American Geriatrics Society (2012) Vol. 60, Iss. 10
Open Access | Times Cited: 592
Current and future treatments for Alzheimer’s disease
Konstantina G. Yiannopoulou, Sokratis G. Papageorgiou
Therapeutic Advances in Neurological Disorders (2012) Vol. 6, Iss. 1, pp. 19-33
Open Access | Times Cited: 591
Konstantina G. Yiannopoulou, Sokratis G. Papageorgiou
Therapeutic Advances in Neurological Disorders (2012) Vol. 6, Iss. 1, pp. 19-33
Open Access | Times Cited: 591
Clinical trials and late‐stage drug development for A lzheimer's disease: an appraisal from 1984 to 2014
L. S. Schneider, Francesca Mangialasche, Nancy C. Andreasen, et al.
Journal of Internal Medicine (2014) Vol. 275, Iss. 3, pp. 251-283
Open Access | Times Cited: 591
L. S. Schneider, Francesca Mangialasche, Nancy C. Andreasen, et al.
Journal of Internal Medicine (2014) Vol. 275, Iss. 3, pp. 251-283
Open Access | Times Cited: 591
Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease
Lesley Jones, Peter Holmans, Marian L. Hamshere, et al.
PLoS ONE (2010) Vol. 5, Iss. 11, pp. e13950-e13950
Open Access | Times Cited: 588
Lesley Jones, Peter Holmans, Marian L. Hamshere, et al.
PLoS ONE (2010) Vol. 5, Iss. 11, pp. e13950-e13950
Open Access | Times Cited: 588
100 Years and Counting: Prospects for Defeating Alzheimer's Disease
Erik D. Roberson, Lennart Mucke
Science (2006) Vol. 314, Iss. 5800, pp. 781-784
Open Access | Times Cited: 548
Erik D. Roberson, Lennart Mucke
Science (2006) Vol. 314, Iss. 5800, pp. 781-784
Open Access | Times Cited: 548
Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: a systematic review and meta-analysis.
Richard A. Hansen, Gerald Gartlehner, Aaron P. Webb, et al.
PubMed (2008) Vol. 3, Iss. 2, pp. 211-25
Closed Access | Times Cited: 506
Richard A. Hansen, Gerald Gartlehner, Aaron P. Webb, et al.
PubMed (2008) Vol. 3, Iss. 2, pp. 211-25
Closed Access | Times Cited: 506
The significance of the cholinergic system in the brain during aging and in Alzheimer’s disease
Reinhard Schliebs, Thomas Arendt
Journal of Neural Transmission (2006) Vol. 113, Iss. 11, pp. 1625-1644
Closed Access | Times Cited: 504
Reinhard Schliebs, Thomas Arendt
Journal of Neural Transmission (2006) Vol. 113, Iss. 11, pp. 1625-1644
Closed Access | Times Cited: 504
